home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Schrodinger, Inc. - Common Stock (NQ:SDGR)

11.50 +0.11 (+0.97%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Schrodinger, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

AI-Powered Drug Discovery Stocks Portfolio Up 14% MTD; Still Down 30% YTD ↗

July 18, 2024

To capitalize on the transition to more AI-focused drug development investors need to understand the drug development process and the financial health and market potential of those companies under...

Via Talk Markets

Schrödinger to Announce Second Quarter 2024 Financial Results on July 31

July 17, 2024

From Schrödinger

Via Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

July 16, 2024

From Schrödinger

Via Business Wire

Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD ↗

July 14, 2024

The 10 clinical-stage AI-focused and psychedelic compound-based drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio are UP 12.8% MTD after having gone DOWN 13.2%, on average,...

Via Talk Markets

What Analysts Are Saying About Schrodinger Stock ↗

July 11, 2024

Via Benzinga

Simulations Plus Stock Drops 15% Despite EPS Beat

July 05, 2024

Simulations Plus fell 15% the day after its earnings release despite beating EPS estimates due to lower margins and lower full-year guidance.

Via MarketBeat

Topics Artificial Intelligence

3 Top-Rated Gene Editing Stocks Actually Making Money ↗

July 03, 2024

Profitable gene editing stocks make increasingly compelling investments as therapies commercialize this year and beyond.

Via InvestorPlace

Largest Clinical-Stage BioTech Drug Stocks Declined 6% ↗

June 22, 2024

Of the 10 clinical-stage AI-focused and psychedelic compound-based small cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, only 1 advanced this week. On average they...

Via Talk Markets

AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th ↗

June 17, 2024

The global

Via Talk Markets

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

June 14, 2024

From Schrödinger

Via Business Wire

AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week ↗

June 10, 2024

The global

Via Talk Markets

The 7 AI Categories Were Down 4%, On Average, This Week; Up 1% In May ↗

June 01, 2024

The 7 AI categories we track dropped, down 4.3% this week, and are now only up 1.3% for the month of May.

Via Talk Markets

Topics Artificial Intelligence

Schrödinger to Present at Jefferies Global Healthcare Conference

May 22, 2024

From Schrödinger

Via Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 17, 2024

From Schrödinger

Via Business Wire

7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs ↗

May 16, 2024

AI continues to impact pharma stocks to buy in a major way, with these shares particularly well positioned as things heat up.

Via InvestorPlace

Topics Artificial Intelligence

What's the Difference Between Biotech Stocks and TechBio Stocks? ↗

May 15, 2024

A few enterprising businesses are marketing themselves differently.

Via The Motley Fool

Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week ↗

May 13, 2024

Via Talk Markets

The 7 AI Categories Declined, On Average, The First Week Of May ↗

May 05, 2024

Via Talk Markets

Topics Artificial Intelligence

Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May ↗

May 05, 2024

We look at the performance of 10 clinical-stage AI-powered and psychedelic compound-based small cap drug discovery companies during the first week of May and YTD.

Via Talk Markets

Etsy Reports Downbeat Earnings, Joins Fastly, DoorDash And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

May 02, 2024

Via Benzinga

SDGR Stock Earnings: Schrodinger Misses EPS, Misses Revenue for Q1 2024 ↗

May 01, 2024

SDGR stock results show that Schrodinger missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 01, 2024

Via Benzinga

Schrödinger Reports First Quarter 2024 Financial Results

May 01, 2024

From Schrödinger

Via Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

April 18, 2024

From Schrödinger

Via Business Wire

The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD ↗

April 15, 2024

The pharmaceutical industry is embracing AI to streamline drug discovery and researching the use of psychedelic compound-based ingredients for the treatment of, as yet, untreatable diseases.

Via Talk Markets

Topics Artificial Intelligence

Schrödinger to Announce First Quarter 2024 Financial Results on May 1

April 10, 2024

From Schrödinger

Via Business Wire

5 Healthcare Stocks to Buy for 2024 ↗

April 02, 2024

Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.

Via InvestorPlace

Topics Artificial Intelligence

Invest Like Bill Gates With These 3 AI Stocks to Buy ↗

March 27, 2024

Bill Gates is undoubtedly interested in AI stocks to buy. Here are three of his foundation’s current holdings.

Via InvestorPlace

Topics Artificial Intelligence

Shhh! 7 Small-Cap Stocks That Can Double by 2025 ↗

March 20, 2024

Small-cap stocks have been hot and these shares discussed here are likely to heat up and double over the next year.

Via InvestorPlace

Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting

March 20, 2024

From Schrödinger

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com